Histopathologic predictors of pilocytic astrocytoma event-free survival

被引:0
作者
Kathleen M. Tibbetts
Ryan J. Emnett
Feng Gao
Arie Perry
David H. Gutmann
Jeffrey Russell Leonard
机构
[1] Washington University School of Medicine,Department of Neurology
[2] Washington University School of Medicine,Department of Biostatistics
[3] Washington University School of Medicine,Division of Neuropathology, Department of Pathology and Immunology
[4] Washington University School of Medicine,Department of Neurosurgery
来源
Acta Neuropathologica | 2009年 / 117卷
关键词
Glioma; Pediatric; CD68; Microglia; Brain tumor; Pilocytic astrocytoma; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
Pilocytic astrocytoma (PA) is the most common pediatric brain tumor. Most arise in the cerebellum, but they also can develop in the brainstem and optic nerve, where gross total resection (GTR) is not possible. In the absence of GTR, significant variability in both clinical behavior and histology exists. To identify potential markers associated with poor clinical outcome, we retrospectively assessed pathological features in 107 patients with PAs. We identified four pathological features (necrosis, oligodendroglioma-like features, vascular hyalinization, and calcification) that showed a significant correlation with decreased event-free survival (EFS). Similar to previous reports, we also found that PAs involving the optic pathway were associated with worse EFS compared with those arising in other locations. In contrast, mitotic index, p53 immunoreactivity and hyperactivation of several mitogenic signaling pathways (MAPK, CREB, mTOR) did not demonstrate a statistically significant relationship with EFS. Lastly, we did find a statistical trend between EFS and the number of CD68+ cells, suggesting that non-neoplastic elements of the tumor microenvironment may influence subsequent growth and clinical recurrence. Collectively, the identification of specific histopathologic features associated with clinical outcome may improve our ability to determine which PAs are more likely to exhibit clinical progression and require more vigilant observation.
引用
收藏
相关论文
共 73 条
  • [11] Zhao NW(1993)Benign astrocytic and oligodendrocytic tumors of the cerebral hemispheres in children Neurosurgery 33 964-997
  • [12] Parsadanian AS(1998)Management and outcome of low-grade astrocytomas of the midline in children: a retrospective review Int J Cancer 76 797-800
  • [13] Gutmann DH(2004)Absence of p53 gene mutations in a tumor panel representative of pilocytic astrocytoma diversity using a p53 functional assay J Neurosurg (Pediatrics 1) 101 1-6
  • [14] Facoetti A(2001)Juvenile pilocytic astrocytoma of the brainstem in children Acta Neuropathol 101 245-248
  • [15] Ranza E(1998)Increased microglia proliferation separates pilocytic astrocytomas from diffuse astrocytomas: a double labeling study Histopath 33 446-452
  • [16] Nano R(2005)MIB-1 and p53 immunocytochemistry for differentiating pilocytic astrocytomas from anaplastic astrocytomas and glioblastomas in children and young adults Neurology 65 13335-13336
  • [17] Fernandez C(2006)RAS pathway activation and an oncogenic RAS mutation in sporadic pilocytic astrocytoma Neurology 66 127-130
  • [18] Figarella-Branger D(2007)Matrilin-2 expression distinguishes clinically relevant subsets of pilocytic astrocytoma Cancer Res 67 890-900
  • [19] Girard N(2008)Distinct genetic signatures among pilocytic astrocytomas relate to their brain region origin J Neurooncol 86 183-190
  • [20] Fisher BJ(2007)Expression of oligodendroglial differentiation markers in pilocytic astrocytomas identifies two clinical subsets and shows a significant correlation with proliferation index and progression free survival Cancer Res 67 8588-8595